mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |